Switch to:
More From Other Websites
ARIAD PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Dec 08 2016
Ariad Pharma Could Draw M&A Fire Ahead Of Second Cancer Drug Win Dec 07 2016
ARIAD PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Dec 07 2016
Dow Scores Another Record for Third Consecutive Day; S&P 500 Also Hits New High Dec 07 2016
Dow, S&P 500 Trade at Session Highs in Broad Wall Street Rally Dec 07 2016
Bernie Sanders' 'Trump Proposal' To Lower Drug Prices Blocked By Senate Republicans Dec 07 2016
ARIAD Presents Data on Brigatinib from the World Conference on Lung Cancer Call scheduled for 10:00... Dec 07 2016
ARIAD’s Investigational Medicine Brigatinib Demonstrated 15.6 Month Systemic Median... Dec 07 2016
7:35 am Ariad Pharm announces Brigatinib demonstrated 15.6 month systemic median progression-free... Dec 07 2016
ARIAD’s Investigational Medicine Brigatinib Demonstrated 15.6 Month Systemic Median... Dec 07 2016
ARIAD Announces Data Presentations at American Society of Hematology Meeting Dec 06 2016
ARIAD Presents Updated Brigatinib Data with 18.4 Months Median Intracranial Progression Free... Dec 05 2016
ARIAD Presents Updated Brigatinib Data with 18.4 Months Median Intracranial Progression Free... Dec 05 2016
ARIAD to Host Webcast and Conference Call on Brigatinib Data Presentations at the World Conference... Dec 02 2016
ARIAD PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Nov 30 2016
Ariad Leukemia Drug Gets Full US Approval (ARIA) Nov 30 2016
ARIAD's Leukemia Drug Iclusig Gets Full Approval in U.S. Nov 30 2016
Hedge Funds Are Souring On Chico’s FAS, Inc. (CHS) Nov 30 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK